Breakthrough: a first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine. [PDF]
Schneider BK +6 more
europepmc +1 more source
Isoindolines and Isoindoline-1,3-diones as Nonpeptide ACE Inhibitors: An <i>In Silico</i> and <i>In Vitro</i> Modeling Approach. [PDF]
Rodríguez JE +5 more
europepmc +1 more source
The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19. [PDF]
Najafi N +9 more
europepmc +1 more source
Correction: Antihypertensive therapy to prevent cardiac death: A study of combined ACE inhibitors and β-blockers-a retrospective cohort study in Tsunan Town, Japan. [PDF]
Ishikawa S, Hayashi Y, Abe T, Tanaka S.
europepmc +1 more source
Angiotensin converting enzyme (ACE) inhibitors activity from purified compounds Fructus Phaleria macrocarpa (Scheff) Boerl. [PDF]
Eff ARY +5 more
europepmc +1 more source
Angiotensin-Converting Enzyme (ACE) Inhibitors and Statins Mitigate Negative Cardiovascular and Pulmonary Effects of Particulate Matter in a Mouse Exposure Model. [PDF]
Junglas T +11 more
europepmc +1 more source
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. [PDF]
Sasongko TH, Nagalla S.
europepmc +1 more source
Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLD. [PDF]
Ryu T +5 more
europepmc +1 more source
ACE inhibitors on ACE1, ACE2, and TMPRSS2 expression and spheroid attachment on human endometrial Ishikawa cells. [PDF]
Fernando SR +9 more
europepmc +1 more source
Antihypertensive therapy to prevent cardiac death: A study of combined ACE inhibitors and β-blockers-a retrospective cohort study in Tsunan Town, Japan. [PDF]
Ishikawa S, Hayashi Y, Abe T, Tanaka S.
europepmc +1 more source

